Leisure Capital Management Sells 1,487 Shares of The Procter & Gamble Company (NYSE:PG)

Leisure Capital Management cut its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 7.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,691 shares of the company’s stock after selling 1,487 shares during the quarter. Procter & Gamble comprises approximately 1.4% of Leisure Capital Management’s holdings, making the stock its 15th largest holding. Leisure Capital Management’s holdings in Procter & Gamble were worth $2,592,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Demars Financial Group LLC raised its stake in shares of Procter & Gamble by 4.4% in the fourth quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock valued at $219,000 after acquiring an additional 63 shares during the last quarter. Emerald Advisors LLC grew its holdings in Procter & Gamble by 1.8% during the 4th quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock worth $553,000 after acquiring an additional 65 shares during the period. O Brien Wealth Partners LLC grew its holdings in Procter & Gamble by 3.3% during the 4th quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock worth $302,000 after acquiring an additional 65 shares during the period. KFA Private Wealth Group LLC grew its holdings in Procter & Gamble by 2.2% during the 3rd quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock worth $445,000 after acquiring an additional 67 shares during the period. Finally, Chemistry Wealth Management LLC grew its holdings in Procter & Gamble by 1.2% during the 4th quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock worth $856,000 after acquiring an additional 67 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Activity

In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the sale, the insider now directly owns 11,507 shares in the company, valued at $1,858,265.43. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of Procter & Gamble stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total value of $4,581,309.81. Following the sale, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the completion of the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 100,865 shares of company stock valued at $16,029,280. Insiders own 0.17% of the company’s stock.

Procter & Gamble Price Performance

Shares of NYSE PG traded down $1.26 during trading hours on Friday, hitting $161.29. 5,659,784 shares of the stock were exchanged, compared to its average volume of 6,820,118. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The company has a market cap of $380.67 billion, a PE ratio of 26.35, a price-to-earnings-growth ratio of 3.30 and a beta of 0.44. The company’s fifty day simple moving average is $159.64 and its two-hundred day simple moving average is $153.51. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $164.32.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. The business had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm’s revenue for the quarter was up .6% on a year-over-year basis. During the same quarter last year, the business posted $1.37 EPS. On average, sell-side analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a dividend of $1.0065 per share. The ex-dividend date is Thursday, April 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.50%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. UBS Group boosted their price target on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. decreased their price target on shares of Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a report on Thursday, January 18th. Jefferies Financial Group upped their target price on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday, April 22nd. Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and upped their target price for the stock from $160.00 to $175.00 in a research note on Monday, March 11th. Finally, Stifel Nicolaus upped their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a research note on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $169.76.

Read Our Latest Analysis on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.